News/ News/ Sales and Marketing J&J says it will stop selling all talc products next year Phil Taylor Baby Powder, Johnson & Johnson, litigation, talc 0 Comment Johnson & Johnson has said it will stop selling talc-based baby powder products globally next year, two years Share X J&J says it will stop selling all talc products next year https://pharmaphorum.com/news/jj-says-it-will-stop-selling-all-talc-products-next-year/
News/ News/ Sales and Marketing J&J settles 1,000 talc lawsuits for $100m+; report Phil Taylor Baby Powder, Johnson & Johnson, litigation, talc 0 Comment Johnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege Share X J&J settles 1,000 talc lawsuits for $100m+; report https://pharmaphorum.com/news/j-report/
News/ News/ News/ Patients/ Sales and Marketing Litigation-weary J&J pulls Baby Powder talc in North America Phil Taylor Baby Powder, Johnson & Johnson, litigation, talc 0 Comment Johnson and Johnson has opted to withdraw one its iconic products – talc-based Baby Powder – from sale Share X Litigation-weary J&J pulls Baby Powder talc in North America https://pharmaphorum.com/news/litigation-weary-jj-pulls-baby-powder-talc-in-north-america/
News/ News/ Patients Jury trial levies $750m damages on J&J over talc and cancer Phil Taylor Johnson & Johnson, litigation, safety, talc, usa 0 Comment The jury in a New Jersey trial has awarded $750 million in punitive damages against Johnson & Johnson Share X Jury trial levies $750m damages on J&J over talc and cancer https://pharmaphorum.com/news/jury-trial-levies-750m-damages-on-jj-over-talc-and-cancer/
News/ News/ Sales and Marketing J&J refutes FDA findings on asbestos in talc Phil Taylor Baby Powder, Johnson & Johnson, litigation, talc 0 Comment Johnson & Johnson has rejected an assertion by the FDA that asbestos had been found in one of Share X J&J refutes FDA findings on asbestos in talc https://pharmaphorum.com/news/jj-refutes-fda-findings-on-asbestos-in-talc/
News/ News/ Oncology J&J hits back over asbestos in talc claims Phil Taylor asbestos, J&J, litigation, talc 0 Comment Shares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had Share X J&J hits back over asbestos in talc claims https://pharmaphorum.com/news/jj-hits-back-over-asbestos-in-talc-claims/
